SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (27193)1/5/1999 12:21:00 PM
From: Mudcat  Read Replies (1) | Respond to of 32384
 
< The Elan deal and the $12 million from the warrants, without dilution, should make the 4th quarter earnings report look pretty good, IMHO.>

Bob, maybe you can explain to me why you think either of these actions will have any effect 4Q earnings?



To: Machaon who wrote (27193)1/5/1999 12:23:00 PM
From: schadenfreude  Read Replies (1) | Respond to of 32384
 

>>The Elan deal and the $12 million from the warrants, without dilution, should make the 4th quarter earnings report look pretty good, IMHO. <<

These financings solidify the balance sheet, but they don't help the earnings. Without product sales or milestone payments, the loss for the quarter will be large reflecting Ligand's high burn rate.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News